EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Tuberculosis Treatment Outcomes in Brazil: Different Predictors for Each Type of Unsuccessful Outcome

Felipe Ridolfi iD, Lauren Peetluk, Gustavo Amorim, Megan Turner, Marina Figueiredo, Marcelo Cordeiro-Santos, Solange Cavalcante, Afrânio Kritski, Betina Durovni, Bruno Andrade, Timothy R Sterling, Valeria Rolla und 1 weitere

Clinical Infectious Diseases · 08.02.2023 · 76 (3) · e930-e937

DOI: 10.1093/cid/ciac541 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 05.07.2022. Verfasst von Felipe Ridolfi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Nacional de Infectologia Evandro Chagas (INI), Fiocruz, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Antitubercular Agents, Tuberculosis. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, DECIT, SCTIE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Successful tuberculosis (TB) treatment is necessary for disease control. The World Health Organization (WHO) has a target TB treatment success rate of ≥90%. We assessed whether the different types of unfavorable TB treatment outcome had different predictors.

Methods

Using data from Regional Prospective Observational Research for Tuberculosis-Brazil, we evaluated biological and behavioral factors associated with each component of unsuccessful TB outcomes, recently updated by WHO (death, loss to follow-up [LTFU], and treatment failure). We included culture-confirmed, drug-susceptible, pulmonary TB participants receiving standard treatment in 2015–2019. Multinomial logistic regression models with inverse probability weighting were used to evaluate the distinct determinants of each unsuccessful outcome.

Results

Of 915 participants included, 727 (79%) were successfully treated, 118 (13%) were LTFU, 44 (5%) had treatment failure, and 26 (3%) died. LTFU was associated with current drug-use (adjusted odds ratio [aOR] = 5.3; 95% confidence interval [CI], 3.0–9.4), current tobacco use (aOR = 2.9; 95% CI, 1.7–4.9), and being a person with HIV (PWH) (aOR = 2.0; 95% CI, 1.1–3.5). Treatment failure was associated with PWH (aOR = 2.7; 95% CI, 1.2–6.2) and having diabetes (aOR = 2.2; 95% CI, 1.1–4.4). Death was associated with anemia (aOR = 5.3; 95% CI, 1.4–19.7), diabetes (aOR = 3.1; 95% CI, 1.4–6.7), and PWH (aOR = 3.9; 95% CI, 1.3–11.4). Direct observed therapy was protective for treatment failure (aOR = 0.5; 95% CI, .3–.9) and death (aOR = 0.5; 95% CI, .2–1.0).

Conclusions

The treatment success rate was below the WHO target. Behavioral factors were most associated with LTFU, whereas clinical comorbidities were correlated with treatment failure and death. Because determinants of unsuccessful outcomes are distinct, different intervention strategies may be needed to improve TB outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsTuberculosisHumansBrazilRisk FactorsTreatment OutcomeRetrospective Studies

Stichwörter der Autor:innen

DOTloss-to-follow-upoutcomestreatmenttuberculosis

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Instituto Nacional de Infectologia Evandro Chagas (INI), Fiocruz, Rio de Janeiro, Brazil.
  • Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, USA.
  • Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT), Manaus, Brazil.
  • Universidade do Estado do Amazonas (UEA), Manaus, Brazil.

ORCID-Profile: Felipe Ridolfi

Förderung

  • NIAID NIH HHS
  • DECIT
  • SCTIE
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Ridolfi, F., Peetluk, L., Amorim, G., Turner, M., Figueiredo, M., Cordeiro-Santos, M., Cavalcante, S., Kritski, A., Durovni, B., Andrade, B., Sterling, T. R., Rolla, V., & Regional Prospective Observational Research in Tuberculosis (RePORT)–Brazil Consortium (2023). Tuberculosis Treatment Outcomes in Brazil: Different Predictors for Each Type of Unsuccessful Outcome. Clinical Infectious Diseases, 76(3), e930-e937. https://doi.org/10.1093/cid/ciac541

Vancouver

Ridolfi F, Peetluk L, Amorim G, Turner M, Figueiredo M, Cordeiro-Santos M, et al. Tuberculosis Treatment Outcomes in Brazil: Different Predictors for Each Type of Unsuccessful Outcome. Clinical Infectious Diseases. 2023;76(3):e930-e937. doi:10.1093/cid/ciac541

BibTeX
@article{Ridolfi2023,
  author = {Ridolfi, Felipe and Peetluk, Lauren and Amorim, Gustavo and Turner, Megan and Figueiredo, Marina and Cordeiro-Santos, Marcelo and Cavalcante, Solange and Kritski, Afrânio and Durovni, Betina and Andrade, Bruno and Sterling, Timothy R and Rolla, Valeria and Regional Prospective Observational Research in Tuberculosis (RePORT)–Brazil Consortium, Regional Prospective Observational Research in Tuberculosis (RePORT)–Brazil Consortium},
  title = {Tuberculosis Treatment Outcomes in Brazil: Different Predictors for Each Type of Unsuccessful Outcome},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {3},
  pages = {e930--e937},
  doi = {10.1093/cid/ciac541}
}
Kostenlos starten →